Biocytogen provides integrated solutions for next-generation antibody drug discovery to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including humanized animal model generation, therapeutic antibody discovery (via RenMab™ Mice), and in vivo/in vitro preclinical pharmacology studies. Biocytogen collaborates with global partners to accelerate new drug discovery and development. Together, we discover innovative medicines for a better, healthier world.